Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-12-17

Clinical Trial Update: Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review

View source ↗

Summary

This document is a systematic review evaluating the use of botulinum toxin to manage idiopathic overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Clínica Infantil Colsubsidio | Conditions: Urinary Bladder, Overactive | Status: UNKNOWN